Menu

Conservation Biologist Ben Collen Dies of Bone Cancer

The University College London researcher investigated how environmental pressures affect animals.

May 22, 2018
Shawna Williams

UNIVERSITY COLLEGE LONDONBen Collen, a University College London PI whose research spanned ecosystems from Antarctica to Brazil, died on Saturday (May 19), according to the university. He was 40 years old. His wife writes on a fundraising page for bone cancer research that he had been fighting the disease for 16 months.

Many of Collen’s colleagues have paid tribute to him on Twitter. Dani Rabaiotti, an author and graduate student at the Zoological Society of London, calls Collen “a brilliant scientist and all round lovely person,” adding, “He was a great mentor to many + his advice helped shape the path I am on now.”

Collen’s lab focused on changes in biodiversity, how species respond to environmental threats, ways to reduce uncertainty in macroecology and biodiversity, and models of the projected ecological effects of different policies.

See “Extinction Risk for Invertebrates

While an undergraduate at Imperial College London, Collen did a stint as a research assistant on a carnivore research project in Kenya. He went on to earn a master’s degree at the University of York and then a PhD from the Institute of Zoology and Imperial College London, according to his lab’s website. He continued his research as a postdoc and, later, a research fellow at the Institute of Zoology, then started his own lab at University College London in 2013.

“Ben was a great conservation scientist but he was also a wonderful person and a central figure in our [Centre for Environment and Biodiversity] community,” according to a memorial written on Collen’s department website. 

The Zoological Society of London selected Collen for its 2014 Marsh Award for Conservation Biology. He was also an Honorary Research Fellow for the United Nations Environment Programme World Conservation Monitoring Centre, and served as an editor for several journals. He was married to science writer Alanna Collen.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.